Stocktoria
Otsuka Holdings Co., Ltd. 4578.T
JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website
Otsuka Holdings Co., Ltd. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | ¥2.47T | ¥2.33T | ¥2.02T | ¥1.74T |
| Gross profit | ¥1.77T | ¥1.67T | ¥1.41T | ¥1.17T |
| R&D expense | ¥352.8B | ¥314.2B | ¥307.8B | ¥275.2B |
| SG&A expense | ¥1.00T | ¥958.3B | ¥807.4B | ¥724.1B |
| Operating income | ¥472.1B | ¥416.0B | ¥291.7B | ¥186.1B |
| Interest expense | ¥27.0B | ¥8.8B | ¥6.5B | ¥6.1B |
| Income tax | ¥101.8B | -¥11.4B | ¥17.2B | ¥35.7B |
| Net income | ¥363.1B | ¥343.1B | ¥121.6B | ¥133.9B |
| EPS (diluted) | ¥685.06 | ¥633.76 | ¥224.10 | ¥246.78 |
| Operating cash flow | ¥403.6B | ¥354.6B | ¥283.2B | ¥211.8B |
| Free cash flow | ¥261.9B | ¥225.3B | ¥168.6B | ¥104.1B |
| Cash & equivalents | ¥534.6B | ¥426.2B | ¥513.3B | ¥471.6B |
| Inventory | ¥374.3B | ¥298.3B | ¥249.6B | ¥223.5B |
| Total assets | ¥4.20T | ¥3.74T | ¥3.36T | ¥3.10T |
| Total liabilities | ¥1.10T | ¥961.1B | ¥924.9B | ¥840.3B |
| Shareholders' equity | ¥3.03T | ¥2.73T | ¥2.39T | ¥2.23T |
Growth · year-over-year · Revenue CAGR 12.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +6.0% | +15.4% | +16.1% | — |
| Net income growth | +5.8% | +182.1% | -9.2% | — |
| EPS growth | +8.1% | +182.8% | -9.2% | — |
| Free cash flow growth | +16.3% | +33.6% | +62.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · JP · as of 2025-12-31. Figures in JPY. Facts plus Stocktoria's own computed scores — not investment advice.